Mannatech (NASDAQ:MTEX) Research Coverage Started at StockNews.com

StockNews.com assumed coverage on shares of Mannatech (NASDAQ:MTEX) in a report published on Sunday. The firm issued a buy rating on the stock.

Mannatech Price Performance

Shares of MTEX opened at $7.53 on Friday. The company has a quick ratio of 0.62, a current ratio of 1.17 and a debt-to-equity ratio of 0.54. The stock has a market cap of $14.19 million, a PE ratio of -8.46 and a beta of 1.17. Mannatech has a 12-month low of $6.75 and a 12-month high of $11.80. The business has a 50-day simple moving average of $7.34 and a two-hundred day simple moving average of $7.75.

Mannatech (NASDAQ:MTEX) last issued its quarterly earnings data on Tuesday, August 13th. The company reported ($0.33) earnings per share (EPS) for the quarter. Mannatech had a negative net margin of 0.97% and a negative return on equity of 11.87%. The business had revenue of $27.74 million during the quarter.

Insider Buying and Selling

In related news, Director Larry A. Jobe sold 16,288 shares of the firm’s stock in a transaction on Monday, September 9th. The stock was sold at an average price of $7.75, for a total transaction of $126,232.00. Following the completion of the transaction, the director now directly owns 54,721 shares of the company’s stock, valued at approximately $424,087.75. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. 41.50% of the stock is currently owned by insiders.

Mannatech Company Profile

Mannatech, Incorporated operates as a health and wellness company in the Americas, Europe, the Middle East, Africa, and the Asia-Pacific. The company develops, markets, and sells nutritional supplements; topical and skin care, and anti-aging products; and weight-management and fitness products. It primarily sells its products directly, as well as through e-commerce and network marketing channels.